Table 3.
Peptide |
Patient sample |
Mean SFU/million | ||
---|---|---|---|---|
Allele | Sequence | Tested | Responded | |
A*01:01 | NSSKVSQNY | 12 | 3 | 79 |
TTEGCQQIM | 7 | 3 | 77 | |
YVDRFFKTL | 7 | 2 | 2,148 | |
SSSKVSQNY | 5 | 2 | 115 | |
NSSQVSQNY | 5 | 4 | 96 | |
HSNQVSQNY | 5 | 4 | 115 | |
HSSQVSQNY | 5 | 4 | 74 | |
NSSQVSRNY | 5 | 3 | 127 | |
SSSQVSQNY | 5 | 4 | 130 | |
B*07:02 | APPAEIFGM | 8 | 1 | 100 |
APRKKGCWK | 8 | 2 | 148 | |
FPQSRPEPT | 7 | 1 | 55 | |
GPGATLEEM | 5 | 1 | 80 | |
GPGHKARVL | 8 | 2 | 83 | |
GPIPPGQMR | 5 | 1 | 215 | |
GPSHKARVL | 8 | 3 | 62 | |
RALGPGATL | 5 | 3 | 115 | |
RLRPGGKKK | 5 | 1 | 135 | |
RPGNFPQSR | 5 | 1 | 80 | |
SPRTLNAWV | 8 | 2 | 245 | |
TPQDLNMML | 5 | 1 | 905 | |
TPQEQIGWM | 5 | 1 | 185 | |
TPQEQLGWM | 4 | 0 | <50 | |
VRMYSPVSI | 4 | 1 | 435 | |
WPSSKGRPG | 8 | 3 | 115 | |
YPLVSLKSL | 8 | 2 | 703 | |
YVDRFFKTL | 8 | 2 | 1,280 | |
GPGHKARVL | 8 | 4 | 84 | |
GPSHKARVL | 8 | 6 | 95 | |
KARVLAEAM | 8 | 5 | 78 | |
QVQHTNIMM | 8 | 6 | 87 | |
QAQQPNVMM | 8 | 5 | 96 | |
QVNGNTAIM | 8 | 6 | 99 | |
QANANTAIM | 8 | 6 | 109 | |
ATNANAAIM | 8 | 5 | 95 | |
NIMMQRGNF | 8 | 3 | 100 | |
NIMMQRSNF | 8 | 6 | 121 | |
NVMMQRSNF | 8 | 6 | 117 | |
AIMMQRGNF | 8 | 4 | 113 |